| 2025 | 2024 | 2023 | 2022 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | 3,6 M € | +28.4% | 2,8 M € | +17.3% | 2,4 M € | -5.2% | 2,5 M € | -3.1% | 2,6 M € | -2.3% | 2,7 M € | -3.7% | 2,8 M € | -21.6% | 3,6 M € | +1.1% | 3,5 M € | ||||||||||
| Gross margin | 406,5 k € | +0.5% | 404,5 k € | -26.0% | 546,9 k € | +496.9% | 91,6 k € | -94.4% | 1,6 M € | -12.4% | 1,9 M € | -14.7% | 2,2 M € | -2.8% | 2,3 M € | +13.3% | 2,0 M € | — | — | — | — | — | — | — | — | — | ||||||||||
| EBITDA | 37,4 k € | +14.1% | 32,8 k € | -82.9% | 191,2 k € | +2087.2% | 8,7 k € | -97.2% | 317,9 k € | -28.6% | 444,9 k € | +8.6% | 409,8 k € | -40.0% | 682,8 k € | +1447.8% | -50,7 k € | -109.9% | 513,6 k € | +177.1% | 185,4 k € | -23.3% | 241,6 k € | +250.9% | 68,9 k € | +124.0% | -287,1 k € | -44.0% | -199,4 k € | +23.0% | -259,0 k € | -507.6% | -42,6 k € | -136.2% | 117,8 k € | |
| Operating profit | 31,2 k € | -4.8% | 32,8 k € | -82.9% | 191,2 k € | +2087.2% | 8,7 k € | -96.7% | 266,1 k € | -15.2% | 313,7 k € | +9.1% | 287,6 k € | -50.6% | 581,6 k € | +319.6% | -264,8 k € | -182.5% | 320,9 k € | +192.2% | 109,8 k € | -38.8% | 179,4 k € | +425.7% | 34,1 k € | +108.8% | -389,5 k € | -72.7% | -225,5 k € | +12.7% | -258,4 k € | -415.3% | -50,1 k € | -145.2% | 110,9 k € | |
| Profit/loss | 22,7 k € | +0.9% | 22,5 k € | -17.0% | 27,2 k € | +670.0% | 3,5 k € | -99.3% | 487,2 k € | +105.7% | 236,8 k € | +15.0% | 205,9 k € | -61.1% | 528,9 k € | +273.8% | -304,3 k € | -218.8% | 256,3 k € | +173.5% | 93,7 k € | -32.0% | 137,8 k € | +21.6% | 113,3 k € | -82.8% | 658,0 k € | +518.6% | 106,4 k € | -59.9% | 265,1 k € | +476.0% | -70,5 k € | -153.3% | 132,4 k € | |
| Equity | 450,5 k € | -0.9% | 454,8 k € | -0.5% | 457,2 k € | -8.6% | 500,1 k € | -22.7% | 646,5 k € | -44.2% | 1,2 M € | +25.7% | 922,5 k € | +2.9% | 896,6 k € | +45.2% | 617,7 k € | -36.5% | 972,0 k € | +1.6% | 957,0 k € | +10.9% | 863,3 k € | +19.0% | 725,4 k € | +18.5% | 612,1 k € | +1433.4% | -45,9 k € | +69.9% | -152,3 k € | +63.5% | -417,4 k € | -20.3% | -346,9 k € | |
| Total assets | 617,8 k € | +9.4% | 564,7 k € | -13.9% | 656,2 k € | -40.2% | 1,1 M € | -39.6% | 1,8 M € | +7.2% | 1,7 M € | -54.6% | 3,7 M € | +91.1% | 2,0 M € | +4.8% | 1,9 M € | -5.3% | 2,0 M € | +26.9% | 1,6 M € | +16.4% | 1,3 M € | +4.7% | 1,3 M € | -14.1% | 1,5 M € | +50.7% | 983,5 k € | -93.0% | 14,0 M € | +1044.0% | 1,2 M € | +2.6% | 1,2 M € | |
| Cash | 388,3 k € | +49.9% | 259,1 k € | +16.1% | 223,1 k € | -69.9% | 742,4 k € | -50.2% | 1,5 M € | +111.2% | 706,4 k € | -56.6% | 1,6 M € | +170.8% | 600,8 k € | +0.4% | 598,4 k € | -12.4% | 683,2 k € | -4.6% | 716,1 k € | -1.6% | 727,6 k € | +13.4% | 641,7 k € | -17.2% | 774,9 k € | +104.6% | 378,7 k € | +12.5% | 336,6 k € | -4.3% | 351,6 k € | -16.3% | 420,1 k € | |
| Debts | 167,3 k € | +59.9% | 104,6 k € | -47.4% | 199,0 k € | -66.0% | 585,6 k € | -49.3% | 1,2 M € | +120.5% | 523,3 k € | -81.3% | 2,8 M € | +167.4% | 1,0 M € | +13.1% | 925,7 k € | -7.3% | 998,4 k € | +67.8% | 595,2 k € | +26.7% | 469,8 k € | -13.2% | 541,1 k € | -32.8% | 805,4 k € | -21.7% | 1,0 M € | -92.7% | 14,1 M € | +778.7% | 1,6 M € | +4.5% | 1,5 M € | |
| Staff | — | — | 1,1 | 5,5 | 5,5 | 9,8 | 9,8 | 8,9 | 7,1 | 7 | 7 | 7 | 6,1 | 6,1 | 5,8 | 6 | 6 | 6 | ||||||||||||||||||
Public limited company · Braine-l'Alleud · incorporated on 08/02/1971
Public limited company profitable and well capitalised. Cash position rising (+49.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MERIDIAN BIOSCIENCE EUROPE is a Public limited company incorporated in 1971. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Braine-l'Alleud.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette